Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Unspecified Adult Solid Tumor, Protocol Specific 1Neuroblastoma 1Leukemia, Myelomonocytic, Acute 1Leukemia, Myeloid, Acute 1Leukemia, Monocytic, Acute 1Leukemia, Erythroblastic, Acute 1Leukemia, Eosinophilic, Acute 1Leukemia, Basophilic, Acute 1Leukemia 1Congenital Abnormalities 1Breast Neoplasms 1

Interventions

Immunoenzyme Techniques 3Docetaxel 3N-(3-chloro-7-indolyl)-1,4-benzenedisulphonamide 2Immunohistochemistry 2AEG 35156 2temsirolimus 1sabarubicin 1halofuginone 1Trabectedin 1SB939 compound 1Reverse Transcriptase Polymerase Chain Reaction 1N-(6-chlorophenoxyhexyl)-N''-cyano-N''-4-pyridylguanidine 1Mass Spectrometry 1Immunologic Techniques 1Flow Cytometry 1Fenretinide 1Chromatography, Liquid 1Bevacizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NETWORK × Unspecified Adult Solid Tumor, Protocol Specific × Chromatography, Liquid × Clear all
NCT00504296 2023-08-04

SB939 in Treating Patients With Locally Advanced or Metastatic Solid Tumors

Canadian Cancer Trials Group

Phase 1 Completed
39 enrolled
Other solid neoplasm

Unspecified Adult Solid Tumor, Protocol Specific

Data powered by HemOnc (CC BY 4.0) Colophon âš¡